Cost:Â Member: $26.25 | Student: $11.25 | Non-member: $48.75
Abstract: Peptide therapy has rapidly expanded within longevity and biohacking spaces, yet its application to complex chronic illness requires fundamentally different clinical reasoning and practice. Dr. Nafysa Parpia has been treating patients with the following diagnoses for the past decade and a half, with a focus on using peptide therapies over the past eight years: Lyme and co-infections, mold/mycotoxin related illness, environmentally acquired illnesses, mast cell activation syndrome (MCAS), and Long COVID. These patients tend to be highly sensitive with multi-systemic and multi-diagnostic illnesses taking place simultaneously. Through her extensive experience treating this patient population with Peptide Therapies and Bioregulators, Dr. Parpia has created a framework by which to modulate immune dysregulation, reduce metaflammation, prepare for detoxification, and treat chronic infections using these substances. This presentation outlines a structured sequencing model—developed through extensive clinical experience—for introducing peptides in a manner that prevents mast-cell activation syndrome, excessive immune activation, or paradoxical reactions common in this population.
Presenter Bio: Dr. Nafysa Parpia is a naturopathic doctor and the Director of Naturopathic Medicine at Gordon Medical. Throughout her career in holistic medicine, she has focused on treating patients with complex chronic illnesses. She specializes in tick-borne illness/Lyme disease, environmentally acquired illness, mold/mycotoxin illness, autoimmunity, fibromyalgia, long haul COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and mast cell activation syndrome (MCAS).